Immunome, Inc.IMNMNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank71
5Y CAGR-4.0%
Studio
Year-over-Year Change

Year-over-year book value per share growth

5Y CAGR
-4.0%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025135.06%
2024-48.86%
2023339.92%
2022-67.11%
20212.13%
2020165.92%
201973.12%
20180.00%